Entera Bio appoints Wagman as Key Clinical Advisor, SAB member
PremiumThe FlyEntera Bio appoints Wagman as Key Clinical Advisor, SAB member
6M ago
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
Premium
The Fly
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
6M ago
Entera Bio Releases Crucial Financial Information Update
Premium
Company Announcements
Entera Bio Releases Crucial Financial Information Update
6M ago
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
PremiumThe FlyEntera Bio announces PK data from oral GLP-2 peptide tablet treatment
8M ago
Entera Bio management to meet virtually with Oppenheimer
Premium
The Fly
Entera Bio management to meet virtually with Oppenheimer
8M ago
Entera Bio management to meet virtually with Oppenheimer
Premium
The Fly
Entera Bio management to meet virtually with Oppenheimer
8M ago
Entera Bio management to meet with Oppenheimer
PremiumThe FlyEntera Bio management to meet with Oppenheimer
8M ago
Entera Bio management to meet with Oppenheimer
Premium
The Fly
Entera Bio management to meet with Oppenheimer
8M ago
Entera Bio Ltd. Maintains Nasdaq Listing with Price Compliance
Premium
Company Announcements
Entera Bio Ltd. Maintains Nasdaq Listing with Price Compliance
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100